Population-scale sequencing resolves determinants of persistent EBV DNA
Memorial Sloan Kettering Cancer Center · Cornell University · +10 more institutions
Abstract
Abstract Epstein–Barr virus (EBV) is an endemic herpesvirus implicated in autoimmunity, cancer and neurological disorders. Although primary infection is often subclinical, persistent EBV infection can drive immune dysregulation and long-term complications. Despite the ubiquity of infection, the determinants of EBV persistence following primary exposure remain poorly understood, although human genetic variation partially contributes to this phenotypic spectrum 1–3 . Here we demonstrate that existing whole genome sequencing (WGS) data of human populations can be used to quantify persistent EBV DNA. Using WGS and health record data from the UK Biobank ( n = 490,560) and All of Us ( n = 245,394), we uncover…
Citation impact
- FWCI
- 84.90
- Percentile
- 100%
- References
- 71
Authors
20- SSSherry S. Y. Nyeo
Memorial Sloan Kettering Cancer Center, Cornell University, Tri-Institutional PhD Program in Chemical Biology
- EMErin M. Cumming
Memorial Sloan Kettering Cancer Center
- OSOliver S. Burren
AstraZeneca (United Kingdom)
- MSMeghana S. Pagadala
Memorial Sloan Kettering Cancer Center
- JCJacob C. Gutierrez
Memorial Sloan Kettering Cancer Center
Topics & keywords
- Genome
- Human genome
- Major histocompatibility complex
- Gene
- Genotyping
- Whole genome sequencing
- Genetic variation
- DNA sequencing
- Good health and well-being